Summary
Highlights
The speaker introduces RA 11166, the HIV and AIDS Policy Act of 2018, and its focus on prevention, treatment, care, and support for PLHIVs and key affected populations. The discussion also touches upon the emerging field of trans health in the Philippines.
The presentation discusses how the old HIV law was insufficient due to increasing incidents among specific populations (MSM, Transgender, 15-24 age group) and did not cater to marginalized, vulnerable, and criminalized communities like people who inject drugs and sex workers. This necessitated a new law with evidence-based strategies and principles like human rights and gender responsiveness.
A significant new provision allows minors (15 years old and above) to access HIV testing without parental consent, especially given the high incidence among this age group and the best interest of the child. It also introduces provider-initiated HIV testing for pregnant women, allowing them to opt out but ensuring they are offered the service and access to ARV treatment to prevent mother-to-child transmission.
The law outlines prohibited acts with higher penalties, including misinformation about HIV cures, unsafe practices leading to transmission, compulsory HIV testing, raids on HIV prevention facilities, and harassment of service providers. The discussion emphasizes that health services should be safe spaces, regardless of a person's legal status.
A key victory for advocates is the prohibition of denying health insurance to PLHIVs. The speaker explains why insurance companies' concerns about profitability are unfounded given government subsidies for ARV. Violation of confidentiality, a pervasive issue, is also discussed, highlighting that any unauthorized disclosure of a person's health status (even beyond HIV) is illegal under data privacy laws.
The law prohibits various forms of discrimination. Implementation challenges are highlighted, particularly the conflict between the HIV law and the campaign against illegal drugs. This conflict creates barriers for key affected populations to access health services due to fear of arrest.
The speaker discusses issues around confidentiality during barangay-level complaints, the reluctance of healthcare professionals to treat minors without parental consent despite legal protections, and the confusion surrounding mandatory HIV testing for OFWs. The concept of 'medical confidentiality' is clarified, allowing healthcare professionals involved in a patient's care to share relevant information without violating privacy, ideally with patient consent.
A new joint memorandum developed by DOH, PNP, DOJ, and CHR establishes special rules of procedure for PLHIV cases. These include strictly confidential proceedings, executive sessions for hearings, and classified records to protect the identity of PLHIVs and affected populations. Legal assistance is available from various government agencies.
The Department of Justice designates special prosecutors for PLHIV cases, and the DOJ Action Center provides assistance. The CHR offers free legal assistance and investigation. Notably, PLHIVs can access free legal representation from the Public Attorney's Office without needing to pass an indigency test. The NBI can also investigate cybercrime violations related to the act.